PEGS EU
Lisbon, PT
November 16–19, 2026
131C
Meet Genedata experts at PEGS EU at booth #131C to learn how Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
To schedule a meeting in advance or to learn more about Genedata solutions, please contact us at info(at)genedata.com.
Presentations
Talk: Digitalizing ADC Discovery: Building an Integrated Data and Workflow Platform
Sameh Eid, Associate Scientific Director - Digital, Data & IT Healthcare, Merck, Darmstadt, Germany
Tuesday, November 17 | 16:50–17:20
Talk: AI-Based Analysis of Label-Free Live Cell Imaging of T Cell Mediated Tumour Killing Assay Enables Competitive and Robust Hit Calling
Josefa dela Cruz-Chuh, Scientist 4, Biochemical and Cellular Pharmacology (BCP), Genentech
Wednesday, November 18 | 14:05–14:35
Poster: Smart Analysis of Experimental Context and Accelerated Biologics Lead Optimization Through AI-Guided Developability Workflows in Hit Profiler
Stephan Steigele, Genedata
Poster: Ensuring Data Quality, Traceability, and Interpretability with Automated Assay Data Workflows
David Schweingruber, Genedata
Poster: An Automated High Throughput Engineering Platform for AI-Supported Developability Predictions
James Moore, Genedata
Poster: A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates
Dario Menendez, Genedata
Poster: In-Depth Characterization of Antibody-Drug Conjugates by Subunit-Level Mass Spectrometry
James Duffy, Genedata
Poster: Brightfield-Only AI Readouts for T-Cell Killing Assays: Label-Free, Segmentation-Free Hit Calling
Josefa dela Cruz-Chuh, Genetech; Stephan Steigele, Genedata
